Novartis (www.Novartis.com) leprosy medicine donation program with WHO extended to 2025; Program has already treated over 7 million patients since 2000; New evidence from contact tracing and ...

In early February 2026, Novartis reported final Phase III ALIGN data showing its IgA nephropathy drug Vanrafia (atrasentan) slowed decline in kidney function versus placebo at multiple timepoints and ...

Decision by Swiss Health Authority follows US Food and Drug Administration (FDA) approval of Entresto in July, serves as an important reference approval for multiple other health authorities Entresto ...

After seven years of groundbreaking work, the University of Pennsylvania and healthcare company Novartis have concluded their exclusive research and development alliance related to immunotherapies.

Novartis is one of the world’s most successful pharma companies and it is undergoing a major change to become a pure-play innovative medicines company. Part of this also involves Novartis pursuing a ...

[BASEL] Novartis forecast a profit decline for 2026, as some of the Swiss drugmaker’s top sellers – such as the heart ...

Iptacopan aims to treat patients with a life-threatening blood disease. If approved, the indication could top $1 billion in sales for the drugmaker. The stock is trading at a discounted valuation ...

A Swiss-based drugmaker plans to double the size of its Indianapolis manufacturing plant, which produces nuclear medicine imaging and therapy products for cancer, in a move that would create 55 jobs ...

Multiyear alliance underpins the Novartis commitment to leverage data & artificial intelligence (AI) to transform how medicines are discovered, developed and commercialized Novartis to establish AI ...

Foundation Medicine is expanding and extending its long-standing collaboration with Novartis to through at least September 2016. The goal of the partnership—the pilot program which was established in ...

TIME reveals the third annual TIME100 Health list, recognizing the 100 most influential individuals in health.